HAE haemonetics.com: Multiplikator Forward P/S
Haemonetics Corporation (HAE) maintains a flawless reputation in the blood processing sector that supports revenue growth, where the 1.50 mark serves as a relevant indicator. Business stability is based on partnerships with plasma centers and quality control during the assembly of systems from external components. The forward P/S ratio demonstrates the current balance of supply and demand, helping to identify shifts in market momentum in a timely manner.
Rincian metrik lan analitis perusahaan Haemonetics Company (HAE)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Haemonetics Corporation|HAE - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Haemonetics Corporation|HAE - Utang perusahaan|Utang marang nilai buku Haemonetics Company|HAE - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Haemonetics|Likuiditas cepet haemonetics.com
- rincian asil keuangan lan kelipatan valuasi:
HAE - Bathi resik taunan|Bathi mangsa ngarep Haemonetics Corporation|HAE - Pangali P/E|Pangali Forward P/E Haemonetics Corp.|HAE - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Haemonetics Company|HAE - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Haemonetics|HAE - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan haemonetics.com|HAE - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Haemonetics Corporation
- indikator volume dodolan lan pendapatan:
Ringkesan analitik perusahaan:Haemonetics (HAE)
This indicator reflects the asset's market value through the lens of expected sales, filtering out short-term noise from quotes by discounting future cash flows. By analyzing the forward P/S trend, an investor can assess the fair revenue premium for Haemonetics Corporation (HAE), considering its equipment's status as a global safety standard in transfusion medicine and the high margins derived from the company's monopoly positions.
Pesaing wigati
Multiplikator Forward P/S DXCM (Dexcom)|Penumbra Inc (PEN) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Novanta Corp - Multiplikator Forward P/S|INSP (Inspire Medical Systems Inc) - Kapitalisasi marang prakiraan pendapatan|PRCT: Multiplikator Forward P/S|CNMD - Rasio kapitalisasi marang dodolan sing dikarepake|PLSE (Pulse Biosciences) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan InMode Ltd (INMD)|Multiplikator Forward P/S PMI|Multiplikator Forward P/S Surmodics Inc. (SRDX)|Rasio rega marang prakiraan pendapatan Senseonics Holdings SENS|neuropace.com - Rasio rega marang prakiraan pendapatan|TCMD: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan SNWV (SANUWAVE Health)|OM: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Electromed (ELMD)|Rasio rega marang prakiraan pendapatan LENSAR, Inc.|RCEL - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan PROF (Profound Medical Corp.)|Multiplikator Forward P/S bairdmed.com (BDMD)|Multiplikator Forward P/S EDAP (EDAP TMS)|Rasio kapitalisasi marang dodolan sing dikarepake Apyx Medical Corp (APYX)|ICCM - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan CytoSorbents Corporation|SRTS (Sensus Healthcare Corp) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Zynex Corp ZYXI|Rasio rega marang prakiraan pendapatan electroCore, Inc. (ECOR)|vicarioussurgical.com - Kapitalisasi marang prakiraan pendapatan|Inspira Technologies - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICU (SeaStar Medical Holding Corporation)|IRIDEX Corp. - Multiplikator Forward P/S|Rega forward marang dodolan INBS (Intelligent Bio Solutions)|XAIR: Multiplikator Forward P/S|profusa.com (PFSA) - Multiplikator Forward P/S|SSKN (STRATA Skin Sciences Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep glucotrack.com GCTK|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|Multiplikator forward rega marang pendapatan Venus Concept Corporation VERO|Rasio rega marang prakiraan pendapatan Nuwellis, Inc. NUWE|aethlonmedical.com (AEMD) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ASXC - Rasio rega marang prakiraan pendapatan|AVGR (Avinger Inc.) - Kapitalisasi marang prakiraan pendapatan|BSGM: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Cutera Inc (CUTR)|Multiplikator forward rega marang pendapatan KNW|NARI (inarimedical.com) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S NVRO|Rasio kapitalisasi marang dodolan sing dikarepake reshapelifesciences.com|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
